Principal Director, Surgical Oncology, BLK-Max Super Speciality Hospital, New Delhi
Part 7 of 9 in Breast Cancer - Diagnosis and Surgical Management
BRCA Testing in Breast Cancer: Who Needs It and What Positive Results Mean
September 21, 2025
BRCA1 and BRCA2 genetic testing is indicated in three situations: all triple-negative breast cancer, since it disproportionately clusters with BRCA mutations; a strong first-degree family history, a sister, mother, or maternal or paternal aunt with breast cancer; and any history of male breast cancer anywhere in the family, which alone is enough to warrant testing regardless of other factors.
What a positive result changes
A confirmed BRCA-positive result changes the surgical plan directly: mastectomy of the affected breast is combined with prophylactic mastectomy of the opposite, unaffected breast, given the substantially elevated risk of a second primary cancer developing there. This is a bilateral procedure specifically because of the mutation, not a default approach for every patient.
Testing access for resource-limited settings
Where BRCA testing is not locally available, Dr. Jain's centre can arrange the test for referred patients, meaning the absence of local genetic testing capacity does not need to be a barrier to identifying which patients genuinely need bilateral surgery.
This article is based on a Jivo Masterclass session conducted by Dr. Rajesh Kumar Jain, Principal Director, Surgical Oncology, BLK-Max Super Speciality Hospital, New Delhi. The article has been summarised with the assistance of an AI tool from the original masterclass recording. Watch the full Masterclass recording
Looking for a breast cancer or surgical oncology consultation or a second opinion? Get in touch with the Jivo team
This guide is based on a live Jivo Masterclass — Dr. Rajesh Kumar Jain taught doctors across Africa on September 21, 2025.
FROM THE LIVE Q&A
Dr. Abraham
Other than PET CT, how can breast cancer be staged using ultrasound and CT scan in a limited setup?
Dr. Rajesh Kumar Jain
A whole-abdomen ultrasound, not just the upper abdomen, checks for liver metastasis and also covers the ovaries and uterus. A chest X-ray checks for lung metastasis. For bone, a skeletal survey, plain X-rays covering the spine, skull and limbs, substitutes for a bone scan where nuclear medicine isn't available. This combination is less accurate than PET CT but is a reasonable, optimal fallback when resources are limited.
Book a Consultation with Dr. Rajesh Kumar Jain
Book on WhatsAppOr message us on WhatsApp: +91 98182 98669
Frequently Asked Questions
For a young unmarried woman with a well-localised, mobile, unilateral lump at stage two or three ductal carcinoma, which surgery is advisable, and can a pre-menopausal patient start tamoxifen before or after surgery?▼
For a young patient with early, well-localised disease, breast conservation surgery is advisable over mastectomy: a wide excision with lymph node dissection or sentinel biopsy, followed by pathology review. If the oestrogen receptor is positive on the final specimen, tamoxifen is started after surgery, and chemotherapy is added if indicated by the pathology. Starting tamoxifen before surgery is not advisable.
Is it possible to start chemotherapy in the patient's home country before sending them for further evaluation and management?▼
Neoadjuvant chemotherapy should be started before referral in two situations: triple-negative breast cancer, and locally advanced disease, meaning a tumour over 5 cm, ulceration, peau d'orange skin change, satellite nodules, or bulky or supraclavicular nodes. In locally advanced disease, surgery follows after around four to four and a half months of chemotherapy. In genuinely advanced or metastatic disease, treatment is systemic only, chemotherapy or hormone therapy, with no surgery. For anything in between, it is always better to discuss the specific case jointly before deciding independently whether and when to start treatment.
If it is familial, should bilateral surgery be done without any further testing?▼
No, a BRCA1 and BRCA2 test should be done first. Indications for testing are all triple-negative breast cancer, a strong first-degree family history (a sister, mother, or maternal or paternal aunt with breast cancer), and any history of male breast cancer in the family, which alone is enough to warrant testing. If the BRCA test comes back positive, mastectomy of the affected breast should be combined with prophylactic mastectomy of the opposite side. If BRCA testing isn't available locally, it can be arranged through Dr. Jain's centre.
What is the definitive treatment for breast cancer?▼
There is no single definitive treatment; breast cancer, like all solid tumours, requires multimodal treatment. Chemotherapy alone, radiotherapy alone, or hormone therapy alone cannot cure it. Surgery has to be part of the treatment plan for a cure, combined with hormone therapy, chemotherapy or radiation as indicated, though surgery alone is occasionally sufficient in very select cases.
Is rehabilitative management necessary after breast cancer treatment?▼
It's mandatory, and Dr. Jain considers it roughly 95% of overall cancer management. Physical rehabilitation covers arm exercises and lifelong protection of the affected arm, no rings, blood pressure cuffs or needles on that side. Psychological rehabilitation matters just as much, since patients carry real emotional weight after a cancer diagnosis, and in some settings social rehabilitation is needed too, since patients can lose their jobs, or in some communities face marital breakdown, because of the diagnosis.
Who should be tested for BRCA1 and BRCA2 mutations?▼
All patients with triple-negative breast cancer, patients with a strong first-degree family history of breast cancer, and anyone with a family history of male breast cancer, which alone warrants testing.
What changes if a breast cancer patient tests BRCA-positive?▼
The surgical plan shifts to mastectomy of the affected breast combined with prophylactic mastectomy of the opposite breast, given the substantially elevated risk of a second primary cancer.
In This Series: Breast Cancer - Diagnosis and Surgical Management
- 1.Breast Cancer Diagnosis and Surgical Management
- 2.Diagnosing a Breast Lump: Imaging Sequence, BI-RADS and When to Biopsy
- 3.Staging Breast Cancer, Including in Settings Without PET CT
- 4.Breast Conservation Surgery vs Mastectomy: How the Decision Is Made
- 5.Axillary Management in Breast Cancer: Sentinel Biopsy and the LYMPHA Technique
- 6.When Chemotherapy Can Be Avoided: Genomic Risk-Stratification in Early Breast Cancer
- 7.BRCA Testing in Breast Cancer: Who Needs It and What Positive Results Mean
- 8.Breast Reconstruction After Mastectomy: Options and Timing
- 9.Rehabilitation and Prognosis After Breast Cancer Treatment